FDA Orange Book · active-ingredient family
Estradiol acetate
Estradiol acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:FEMTRACE · NDA 021633
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · insert, extended release, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FEMTRACERLD×3 | APIL | NDA 021633 | — | Aug 20, 2004 | |
| FEMRINGRLD×2 | MILLICENT MFG PR | NDA 021367 | — | Mar 20, 2003 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Estradiol acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

